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A B S T R A C T
Background
Reminiscence Therapy (RT) involves the discussion of past activities, events and experiences with another person or group of people,
usually with the aid of tangible prompts such as photographs, household and other familiar items from the past, music and archive sound
recordings. Reminiscence groups typically involve group meetings in which participants are encouraged to talk about past events at least
once a week. Life review typically involves individual sessions, in which the person is guided chronologically through life experiences,
encouraged to evaluate them, and may produce a life story book. Family care-givers are increasingly involved in reminiscence therapy.
Reminiscence therapy is one of themost popular psychosocial interventions in dementia care, and is highly rated by staff and participants.
There is some evidence to suggest it is effective in improving mood in older people without dementia. Its effects on mood, cognition
and well-being in dementia are less well understood.
Objectives
The objective of the review is to assess the effects of reminiscence therapy for older people with dementia and their care-givers.
Search methods
The trials were identified from a search of the Specialised Register of the Cochrane Dementia and Cognitive Improvement Group on
4 May 2004 using the term “reminiscence”. The CDCIG Specialized Register contains records from all major health care databases
(MEDLINE, EMBASE, PsycLIT, CINAHL) andmany ongoing trials databases and is regularly updated.We contacted specialists in the
field and also searched relevant Internet sites. We hand-searched Aging and Mental Health, the Gerontologist, Journal of Gerontology,
Current Opinion in Psychiatry, Current Research in Britain: Social Sciences, British Psychological Society conference proceedings and
Reminiscence database.
Selection criteria
Randomised controlled trials and quasi-randomized trials of reminiscence therapy for dementia.
Data collection and analysis
Two reviewers independently extracted data and assessed trial quality.
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Main results
Five trials are included in the review, but only four trials with a total of 144 participants had extractable data. The results were statistically
significant for cognition (at follow-up), mood (at follow-up) and on a measure of general behavioural function (at the end of the
intervention period). The improvement on cognition was evident in comparison with both no treatment and social contact control
conditions. Care-giver strain showed a significant decrease for care-givers participating in groups with their relative with dementia, and
staff knowledge of group members’ backgrounds improved significantly. No harmful effects were identified on the outcome measures
reported.
Authors’ conclusions
Whilst four suitable randomized controlled trials looking at reminiscence therapy for dementia were found, several were very small
studies, or were of relatively low quality, and each examined different types of reminiscence work. Although there are a number of
promising indications, in view of the limited number and quality of studies, the variation in types of reminiscence work reported and
the variation in results between studies, the review highlights the urgent need for more and better designed trials so that more robust
conclusions may be drawn.
P L A I N L A N G U A G E S U M M A R Y
Inconclusive evidence of the efficacy of reminiscence therapy for dementia
RT involves the discussion of past activities, events and experiences, with another person or group of people. This is often assisted by aids
such as videos, pictures, archives and life story books. Four randomized controlled trials suitable for analysis were found. Several were
very small studies, or were of relatively low quality, and each examined different types of reminiscence work. Taking studies together,
some significant results were identified: cognition and mood improved 4 to 6 weeks after the treatment, care-givers participating with
their relative with dementia in a reminiscence group reported lower strain, and people with dementia were reported to show some
indications of improved functional ability. No harmful effects were identified on the outcome measures reported. However, in view of
the limitations of the studies reviewed, there is an urgent need for more quality research in the field.
B A C K G R O U N D
Reminiscence work was introduced to dementia care over 20 years
ago (Norris 1986), and has taken a variety of forms. At its most
basic, it involves the discussion of past activities, events and ex-
periences, usually with the aid of tangible prompts (e.g. pho-
tographs, household and other familiar items from the past, music
and archive sound recordings).
The development of reminiscence work is usually traced to Butler
1963’s early work on “Life Review”. Butler described Life Review
as a naturally occurring process where the person looks back on
his/her life and reflects on past experiences, including unresolved
difficulties and conflicts. This concept was incorporated in a psy-
chotherapy for older people, which emphasizes that life review can
be helpful in promoting a sense of integrity and adjustment. But-
ler’s seminal work contributed to the change in professional per-
spectives on reminiscence. Rather than being viewed as a problem,
with the older person ’living in the past’, reminiscence was now
seen as a dynamic process of adjustment. However, also around
this time, increasing interest in oral historymeant that the reminis-
cences of older people were valued more greatly. In the UK the de-
velopment of the ’Recall’ tape-slide package (Help the Aged 1981)
meant that reminiscence triggers were widely available in day care
centres, care homes and hospitals, leading many staff to establish
some form of reminiscence work of variable quality. There was
also interest in using reminiscence to guide environmental design
on the basis that, say, a lounge of a care home which resembled
a living room from earlier in the person’s life would seem more
familiar and might lead to better maintenance of independence.
There is some evidence that reminiscence work assists in the re-
duction of symptoms of depression in older people (Bohlmeijer
2003; Scogin 1994). However, it is important to distinguish life
review therapy from a more general reminiscence discussion in a
group context. Life review therapy hasits roots in psychotherapy,
involving evaluation of personal (sometimes painful) memories
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with a therapeutic listener, usually in a one-to-one setting. Gen-
eral reminiscence in a group context has the aim of enhancing in-
teraction in an enjoyable, engaging fashion (Haight 1993; Woods
1992). Both types of approach might plausibly have an impact on
mood and well-being.
Reminiscence work also has a cognitive rationale. People with de-
mentia often appear able to recall events from their childhood, but
not from earlier the same day. Accordingly a promising strategy
appeared to be to tap into the apparently preserved store of remote
memories. By linking with the person’s cognitive strengths in this
way, it was thought that the person’s level of communicationmight
be enhanced, allowing the person to talk confidently of their earlier
life and experiences. In fact, studies of remotememory suggest that
recall for specific events is not relatively preserved; performance
across the lifespan is impaired but people with dementia, like all
older people, recall morememories from earlier life (Morris 1994).
Some of the memories represent well-rehearsed, much practised
items or anecdotes. The almost complete absence of autobiograph-
ical memories from the person’s middle years could lead to a dis-
connection of past and present, which could contribute to the
person’s difficulty in retaining a clear sense of personal identity.
From a cognitive standpoint, autobiographical memory and level
of communication appear key outcomes.
The first study identified as having been conducted with a group
of older people with dementia was reported by Kiernat 1979. Al-
though this was an uncontrolled study using subjective assess-
ment, Kiernat 1979 concluded that “Conversation can be stimu-
lated, interest can be sparked and attention span can be increased”.
Since 1979, there have been various studies using reminiscence
approaches with dementia populations (Woods 1995), usually in
a group context (including Cook 1984; Lesser 1981). However,
very few randomized controlled trials have been conducted (Baines
1987; Goldwasser 1987; Orten 1989). More recently, there have
been further developments in reminiscencetherapy; for example,
there has been much interest in conducting reminiscence sessions
jointly with people with dementia and their family care-givers
(Bruce 1998; Thorgrimsen 2002); and an increasing interest in
psychotherapeutic work with people with dementia has led to
some attempts to utilise life review with people with dementia
(Lai 2004; Morgan 2000) and life review with the person with
dementia and family care-giver together (Haight 2003).
The implications of this background for the current review are as
follows:
1) The type of reminiscence work and its aims needs to be clearly
defined. There are a number of ways inwhich reminiscencemay be
used with people with dementia (Gibson 1994) on an individual
or a group basis:
• as a basis for care-planning;
• for discussion of general memories or of more specific
autobiographical memories as might be involved in creating a
life-story book;
• involving family care-givers or volunteers;
• the person with dementia may be in a group with other
people with dementia or with cognitively intact older people.
Aims might be to enhance communication, to increase a sense of
personal identity, to have an enjoyable activity in company with
others, to improve mood and well-being, to stimulate memories
and/or to increase the individualisation of care.
2) Different outcome measures may be appropriate according to
the type of reminiscence work and its aims. The list given above
suggests that improvements in general cognition and behaviour
might be the least of the changes expected, except as an indirect
consequence of mood change perhaps.
3) The impact on others than the person with dementia may also
be important, particularly where family care-givers are involved
in the reminiscence work. Baines 1987 examined staff knowledge
of those attending group sessions; this increased in reminiscence
groups compared with no treatment, but also increased with a
comparison treatment (Reality Orientation), so may not be a spe-
cific effect. Knowledge regarding the person with dementia is of
course a prerequisite for individualized care.
4) Memories from the person’s earlier life will not all be sources of
pleasure and happiness; indeed some may be distressing or trau-
matic. Evaluation of any negative impact of this approach is re-
quired, to monitor whether the recall of such memories occurs,
and, if it does, whether these can be managed safely within the
particular therapeutic context.
O B J E C T I V E S
This review considers the effects of reminiscence therapy on people
with dementia and their care-givers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) which include reminis-
cence therapy of any type as an intervention for dementia were
included in the review. RCTs of psychosocial interventions of this
type cannot be double-blind, as therapists and participants are
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aware of the nature of the intervention, but good quality studies
will include post-treatment assessment by assessors blind to treat-
ment allocation.
Types of participants
Older people (mean age > 55) diagnosed with dementia, cognitive
impairment, Alzheimer’s disease, organic brain syndrome, etc. ac-
cording to DSM-IV, ICD-10 or comparable. If groups of partic-
ipants are mixed (i.e. people with and without dementia partici-
pating together), separate results for people with dementia must
be available.
Types of interventions
Regular individual sessions or meetings of small groups, which
involve the process of reminiscing, possibly aided by means such
as photographs, music and videos of the past. Only trials where
participants attended for a minimum 4-week period (minimum
of 6 sessions) and sessions were led by professional staff (psycholo-
gists, occupational therapists, nurses etc.) or by care-workers with
training from professional staff were included. Control interven-
tions may include other types of activity (to control for effects of
staff attention or social contact) or a no treatment (’treatment as
usual’) comparison; comparisons with other therapeutic interven-
tions (like reality orientation or music therapy) are not considered
in this review.
Types of outcome measures
Key outcomes considered are:
• Well-being, mood and quality of life
• Communication and interaction
• Cognition - particularly autobiographical memory
• Impact on care-givers e.g. care-giver strain or staff
knowledge of information regarding the person with dementia
Maintaining changes is anticipated to be an issue in this inter-
vention with people with dementia, and demonstration of bene-
fit immediately after the series of treatment sessions is a priority,
before evaluating longer-term benefits. Changes occurring within
treatment sessions may be demonstrable (e.g. Brooker 2000; Head
1990) but are outside the scope of this review.
Potential negative effects of reminiscence therapy may be evalu-
ated through negative changes in mood and well-being, and may
have an impact on ratings of levels of independence and problem
behaviour.
Search methods for identification of studies
The trials were identified from a search of the Specialised Register
of the Cochrane Dementia and Cognitive Improvement Group
on 4 May 2004 using the term reminiscence.
The Specialized Register at that time contained records from the
following databases:
CENTRAL: January 2004 (issue 1);
MEDLINE: 1966 to 2004/02;
EMBASE: 1980 to 2004/02;
PsycINFO: 1887 to 2004/01;
CINAHL: 1982 to 2004/01;
SIGLE (Grey Literature in Europe): 1980 to 2002/12;
ISTP (Index to Scientific and Technical Proceedings): to May
2000;
INSIDE (BL database of Conference Proceedings and Journals):
to June 2000;
Aslib Index to Theses (UK and Ireland theses): 1970 to March
2003;
Dissertation Abstract (USA): 1861 to March 2003;
ADEAR (Alzheimer’s Disease Clinical Trials Database): to March
2004;
National Research Register: Issue 1/2004;
Current Controlled trials (last searched March 2004) which in-
cludes:
Alzheimer Society
GlaxoSmithKline
HongKong Health Services Research Fund
Medical Research Council (MRC)
NHS R&D Health Technology Assessment Programme
Schering Health Care Ltd
South Australian Network for Research on Ageing
US Dept of Veterans Affairs Cooperative Studies
National Institutes of Health (NIH)
ClinicalTrials.gov: last searched March 2004;
LILACS (Latin American and Caribbean Health Science Litera-
ture): last searched April 2003.
The search strategies used to identify relevant records in MED-
LINE, EMBASE, PsycINFO, CINAHL and LILACS can be
found in the Group’s module.
The reviewers hand-searched:
1. British Psychological Society conference proceedings (Feb and
Aug 1997)
2. Reminiscence database (Collated by M. Bender, 1995)
Additional sources:
1. The Alzheimer’s Society library
2. Letters were published in PSIGE (Psychologists Special Interest
Group for the Elderly) and the BPS (British Psychological Society)
magazines, requesting information on any controlled trials which
may not easily be discovered (eg. unpublished papers.)
3. Personal contact was made with various specialists in the field.
Additionally, reference lists of all papers were searched for further
references, and reviewers searched personal holdings of references
to reports and trials. Letters/e-mails were sent to all authors of
controlled trials asking for essential information, where this was
not available in the publication (e.g. statistics and/or details of
randomization).
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Data collection and analysis
SELECTION OF TRIALS
For the original review (1998), 15 publications were identified
through the literature searches.Where possible, abstracts were read
before obtaining papers, but inmany cases, decisions as to whether
or not to obtain the paper were based on the title. A reviewer (AS)
and co-reviewer (MO) independently assessed eligibility.
For this substantive update (2004), a further 16 relevant papers
were identified from the literature searches and reviewed against
the eligibility criteria.
DATA EXTRACTION
Data were extracted on changes in cognition, behaviour, commu-
nication, mood/well-being and impact on care-givers assessed us-
ing psychometric tests and rating scales. Descriptive characteris-
tics (such as quality of randomization and blinding) and study
results were extracted. Additionally, letters/e-mails were sent to all
authors of controlled trials asking for essential information, where
this was not available in the publication (e.g. statistics and/or de-
tails of randomization).
Data were extracted from the published reports. The summary
statistics required for each trial and each outcome for continuous
data are the mean change from baseline, the standard error of
the mean change, and the number of patients for each treatment
group at each assessment. Where changes from baseline were not
reported, themean, standard deviation and the number of patients
for each treatment group at each time point were extracted if
available.
The baseline assessment is defined as the latest available assessment
prior to randomization, but no longer than two months prior.
For each outcome measure, data were sought on every patient ran-
domized. To allow an intention-to-treat analysis, the data were
sought irrespective of compliance, whether or not the patient was
subsequently deemed ineligible, or otherwise excluded from treat-
ment or follow-up. If intention-to-treat data were not available in
the publications, “on-treatment” or the data of those who com-
plete the trial were sought and indicated as such.
In studies where a cross-over design was used, only data from the
first treatment phase after randomization was eligible for inclu-
sion.
DATA ANALYSIS
The outcomesmeasured in clinical trials of dementia and cognitive
impairment often arise fromordinal rating scales.Where the rating
scales used in the trials have a reasonably large number of categories
(more than 10) the data were treated as continuous outcomes
arising from a normal distribution.
Summary statistics (n,mean and standard deviation) were required
for each rating scale at each assessment time for each treatment
group in each trial for change from baseline. For crossover trials
only the data from the first treatment period was used.
When change frombaseline results were not reported, the required
summary statistics were calculated from the baseline and assess-
ment time treatment group means and standard deviations. In
this case a zero correlation between the measurements at baseline
and assessment time was assumed. This method overestimates the
standard deviation of the change from baseline, but this conserva-
tive approach is considered to be preferable in a meta-analysis.
The meta-analysis requires the combination of data from the tri-
als that may not use the same rating scale to assess an outcome.
The measure of the treatment difference for any outcome was the
weighted mean difference when the pooled trials use the same rat-
ing scale or test, and the standardised mean difference, which is
the absolute mean difference divided by the standard deviation
when they used different rating scales or tests.
Overall estimates of the treatment difference are presented. In all
cases the overall estimate fromafixed effectsmodel is presented and
a test for heterogeneity using a standard chi-square statistic and the
I2 was performed. If, however, there is evidence of heterogeneity of
the treatment effect between trials then either only homogeneous
results were pooled, or a random-effects model was used (in which
case the confidence intervals would be broader than those of a
fixed-effects model).
In order to allow comparisons with other scales assessing similar
outcomes, it has been necessary to reverse the sign of certain scales
e.g. measures of depression. References for and details of the mea-
sures used in the included studies are provided in Table 1.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
The five included studies are as follows:
Baines 1987 included 15 subjects with ’moderate to severe im-
pairment of cognitive functioning’. No details of further illnesses
or medication were given. Subjects were randomly assigned to 3
groups of 5: they received initially RT, Reality Orientation (RO)
or no treatment. Intervention (RT and RO) was for 30 minutes,
5 times a week for 4 weeks. RT sessions were based on the format
suggested by Norris 1986; using a set of audio/slide programmes
designed to facilitate reminiscence, old photographs (local scenes
and personal), books, magazines, newspapers and domestic arti-
cles. After a further 4 week gap, the RT and RO groups crossed-
over to receive the alternate therapy, whilst the no treatment group
continued as previously. In this review, the initial RT versus no
treatment comparison is considered, together with the compari-
son after a further 4 weeks. Outcomes measured included the In-
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formation/Orientation test and the Behaviour Rating Scale from
the Clifton Assessment Procedures for the Elderly (CAPE) (Pattie
1979); the Holden Communication Scale, Life Satisfaction Index
(LSI) and a Problem Behaviour Rating Scale, all completed be-
fore and immediately after the 4-week intervention. The cognitive
assessment and LSI were completed by an independent psychol-
ogist and the behaviour rating scales and Communication Scale
rated by staff who were not involved with the therapy groups. Staff
knowledge regarding residents’ backgrounds was assessed using a
Personal Information questionnaire, with staff responses pooled
for each participant.
Goldwasser 1987 included 30 subjects with a clinical diagnosis
of dementia. No details of further illnesses or medication were
given. They were randomly assigned to 3 groups of 10: RT, Social
support and no treatment. Intervention (RT and social support)
was for 30 minutes, twice a week for 5 weeks. Reminiscence topics
included food, family, early memories, adjustments, losses, jobs
andmusic. The social support group focused on present and future
events and problems. Outcomes measured were cognition, ADL
(Activities of Daily Living - behaviour) andseverity of depression;
pre-intervention, 1week post-intervention and at a 6-week follow-
up.
Thorgrimsen 2002- one of the three new trials - reports an eval-
uation of a reminiscence group programme which involves fam-
ily care-givers alongside the person with dementia; indeed, there
were 18 weekly sessions for care-givers, with 7 of these sessions
being attended by the person with dementia. Participants, ran-
domly assigned to RT treatment or no treatment, were 11 people
with a diagnosis of dementia, living in the community, and 11
informal family care-givers. No details are given of how the diag-
nosis was established, of medication or co-morbid illnesses. The
mean initial MMSE score (13) suggests a moderate degree of cog-
nitive impairment. Sessions with care-givers alone were intended
to train them in the use of reminiscence methods. In joint sessions,
topics included ’school days’, ’the world of work’ and ’dressing
up and looking good’, with slides, enlarged photographs, music
and drama being used to bring memories to life. Outcome mea-
sures included the MMSE (the Mini Mental State Examination
(Folstein 1975): a screening test of cognitive function, including a
number of orientation items), the QOL-AD, a 13 item quality of
life scale specifically developed for use with people with dementia
(Logsdon 1999), the Behaviour Rating Scale from the CAPE, the
HoldenCommunication Scale and two scales intended to evaluate
change in the level of carer strain (the GHQ-12 (Goldberg 1978)
and the Relatives Stress Scale). Carers and people with dementia
were assessed separately, immediately before and immediately after
the 18 week intervention period, with the assessor blind to group
allocation. The QOL-AD was completed by the person with de-
mentia on their own behalf, and by the carer, rating the person
with dementia’s quality of life.
Lai 2004 - the second of the new included trials - included 101
nursing home residents, with 36 participating in individual rem-
iniscence sessions, involving ’highly focused use of triggers that
approximate the life history of an individual’. In addition to a no
treatment control group, there was also a social contact compari-
son group, again involving individual sessions. Sessions were held
once weekly for six weeks, and lasted 30 minutes, each facilitated
by a personal care worker and a research assistant. Participants were
diagnosed with dementia, according toDSM-IV criteria, and were
able to communicate. Exclusion criteria included the presence of
other active major psychiatric disorders, acute or unstable chronic
medical conditions, and severe uncorrected sensory impairments.
The sample appear to have amoderate to severe degree of cognitive
impairment, with a mean MMSE score of 9, and around half the
sample were reported to be continually restrained. Medication use
did not differ between groups. Outcome measures were the Social
Engagement Scale, where a care-giver rates the person’s comfort in
social situations and the Well-being / Ill-being Scale(WIB), from
the Dementia Care Mapping tool, which involves direct observa-
tion of the person every five minutes for a minimum of six hours
in the home. Although not reported in the published version of
the study, the author has made available data on the MMSE and a
self-care rating scale (the MDS-ADL) for this review. Assessments
were carried out immediately before and after the 6 week treat-
ment period, and at a 6 week follow-up.
Morgan 2000 - the third new included trial -included17 care home
residents, each with a mild to moderate degree of dementia on the
Clinical Dementia Rating Scale (CDR) (Hughes 1982). Exclusion
criteria were presence of florid psychosis and severe communica-
tion difficulty. All had a carer or relative who agreed to support
the intervention. The life review group received an average of 12
individual weekly sessions, following Haight’s Life Review Expe-
riencing Form (Haight 1992); a life story book was developed for
each person in the intervention group, incorporating the person’s
own words, accompanied by appropriate pictures; the focus in ses-
sions was on evaluative life review. The comparison was a no treat-
ment control. Outcome measures included the 15 item Geriatric
Depression Scale (Yesavage 1983), the Life Satisfaction Index - A
and the Autobiographical Memory Interview Personal Semantic
Schedule (PSS) (Kopelman 1990). Assessments were carried out
immediately before and after the intervention period and at 6week
follow-up. No details are available of medication use or other co-
morbid illnesses.
Risk of bias in included studies
1) SELECTION BIAS
Baines 1987: Method of randomization unclear.
Goldwasser 1987: Method of randomization unclear.
Thorgrimsen 2002: Randomization using sealed envelopes.
Lai 2004: ’Fixed allocation’ was practised.
Morgan 2000: Randomization by minimisation method used,
with age and relationship to care-giver stratifying variables.
2) PERFORMANCE BIAS
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With psychological interventions, unlike drug trials, it is impos-
sible to blind patients and staff totally to treatment. Patients will
often be aware that they are being treated preferentially, staff in-
volved may have different expectations of treatment groups, and
independent assessors may be given clues from patients during the
assessments. There may also be contamination between groups, in
terms of groups not being held in separate rooms and staff bring-
ing ideas from one group to another. The latter effect would be
reduced with clear therapeutic protocols.
Baines 1987
Staff were unaware of the allocation of patients to groups, as they
were removed from the setting for treatment. Contamination: RT
group was held in a separate room, but the same staff conducted
RO and RT, so they could have discussed the 2 groups, and come
up with common solutions which are not within the boundaries
of RT. This would be less likely if there was a written treatment
protocol, of which there is no evidence.
Goldwasser 1987
No details are given of where sessions were held. The same facili-
tators conducted RT and social support, which may have resulted
in some contamination across groups.
Thorgrimsen 2002
Intervention followed a standardised manual. By design, families
were aware of treatment allocation.
Lai 2004
Interventions delivered by professional staff with additional train-
ing; video-tapes of intervention and comparison conditions re-
viewed by expert panel to assure adherence to treatment proto-
col, despite same staff conducting intervention and comparison
groups.
Morgan 2000
All interventions delivered by primary researcher. Home staff and
family aware of treatment allocation.
3) ATTRITION BIAS
Baines 1987
0/15 dropouts
Goldwasser 1987
3/30 dropouts. 1 person in RT group died, therefore 1 person in
each of the other 2 groups was randomly dropped.
Thorgrimsen 2002
1/11 drop-out (from control group)
Lai 2004
Intention to treat analysis; 86/101 completed post-test assessment;
79/101 completed follow-up assessment. Attrition spread evenly
across conditions (reported as 3/30 no treatment; 6/35 social con-
tact; 6/36 reminiscence).
Morgan 2000
2/19 dropped out (both from intervention group).
4) DETECTION BIAS
Baines 1987
Assessments were made by an independent psychologist, and staff
whoknew the residentswell butwere not involvedwith the therapy
groups.
Goldwasser 1987
Assessments were made by a psychology graduate, a registered
nurse and a ’practical nurse’, none of whom were aware of the
conditions to which subjects were assigned.
Thorgrimsen 2002
Assessments were made by a psychologist unaware of group al-
location; families were asked to maintain ’blindness’ of assessor.
CAPE Behaviour and Holden Communication Scale were rated
by a family member present at group sessions.
Lai 2004
All assessors blind to group allocation. Extensive training given in
the use of the measures, and good inter-rater reliabilities achieved
at baseline and mid-study.
Morgan 2000
Baseline assessments carried out by the primary researcher. Half
of post-therapy and follow-up assessments for both groups carried
out by a psychologist unaware of group allocation.
Overall, the included trials have important methodological weak-
nesses, particularly in relation to small sample size and difficulties
in carrying out post-treatment assessments ’blind’ to treatment
condition. Whilst all report randomisation, details of the methods
used are lacking. Only one study (Lai 2004) attempted to evaluate
adherence to the treatment protocol.
Effects of interventions
Itwas not possible to obtain adequate data for entry intoMetaView
from the Goldwasser 1987 study. The authors reported a slight,
but insignificant improvement in cognitive status for the RTgroup
compared to the 2 others, no differences at all in behavioural
assessment, and a significant increase in depression for the RT
group. The latter measure may have been biased because initial
depression scores were higher for this group.
Four trials (Baines 1987; Lai 2004; Morgan 2000; Thorgrimsen
2002) were included in the analyses. In comparison with no treat-
ment, at the post-treatment assessment reminiscence was asso-
ciated with significantimprovements on both measures of care-
giver strain used by Thorgrimsen 2002 (GHQ: weighted mean
difference 2.9; 95% confidence intervals (CI) 0.22 to 5.58; z =
2.12, p = 0.03; Relatives Stress Scale: weighted mean difference
18.8; 95% CI 6.45 to 31.15; z = 2.98, p = 0.003). There were
also significant improvements in staff knowledge regarding resi-
dents (weighted mean difference 19.8; 95% CI 15.64 to 23.96; z
= 9.33, p < 0.00001) and improved behavioural functioning on
the CAPE BRS (weighted mean difference 7.61; 95% CI 2.42 to
12.8; z = 2.88, p = 0.004). At 4 or 6 week follow-up, reminis-
cence was associated with significant improvements in cognition
(standardised mean difference 0.5; 95% CI 0.07 to 0.92; z = 2.31,
p = 0.02) and in depression (assessed only in the Morgan 2000
study; weighted mean difference 3.69; 95% CI 1.65 to 5.73; z =
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3.55, p = 0.0004).No differences in communication / interaction
or problem behaviour were evident at either time point.
One trial, Lai 2004 (the largest of the four), included a social
contact comparison group; no significant effects of reminiscence
were evident in comparison to the social contact intervention on
communication, behaviour or well-being, immediately post-treat-
ment or at 6 weeks follow-up. There was, however, a significant
improvement on cognition (as measured by theMMSE) at 6 week
follow-up (weighted mean difference 4.37; 95% CI 0.72 to 8.02;
z = 2.35, p = 0.02).
D I S C U S S I O N
This review has indicated some potentially beneficial effects of RT,
with analyses involving the four eligible RCTs. These include im-
provements in cognition - particularly helped by the inclusion of a
measure of autobiographical memory in one study - and onmood,
consistent with findings on the use of reminiscence with older peo-
ple without dementia (Bohlmeijer 2003). Although both these im-
provements were significant only 4 to 6 weeks after the end of the
intervention period, in the case of cognition there was an encour-
aging trend at post-treatment. More surprisingly, there was a sig-
nificant improvement in scores on the CAPE Behavioural Rating
Scale at post-treatment; this scale of general behavioural function
covers self-care and communication skills as well as having a couple
of items onbehavioural disturbance.No improvementswere noted
on theMDS-ADL scale. In the studywhere family care-givers were
involved in the reminiscence groups (Thorgrimsen 2002), care-
giver strain was significantly reduced. Staff knowledge regarding
participants’ backgrounds increased dramatically compared with
their knowledge regarding those in a no treatment condition.
Whilst these findings are encouraging, and add some weight to
the many favourable evaluations of reminiscence work that have
arisen from descriptive and observational studies (e.g. Cook 1984;
Gibson 1994; Kiernat 1979) there are a number of limitations to
the strength of the conclusions that may be drawn at this stage.
1) Each of the additional trials includes a different type of reminis-
cence work. Ideally, comparisons between different reminiscence
modalities would be made e.g. individual versus group; involving
family care-givers versus people with dementia alone; involving
life review versus more general reminiscence. Until further, large-
scale, good quality trials become available it will not be possible
to draw conclusions regarding different reminiscence modalities.
2) Although comparisons are difficult, with different measures of
severity used in each study, it does appear that the largest RCT
included here (Lai 2004) may have involved a more severely im-
paired group than other trials, which have mainly included peo-
ple with mild / moderate dementia. It is likely that therapeutic
approaches need to be tailored to the degree of impairment of the
participants, and it is possible that efficacy may differ at different
levels of severity of dementia, and possibly interact with the type
of reminiscence work undertaken.
3) The high levels of continual restraint used with the more im-
paired group in the Lai 2004 study also makes comparisons dif-
ficult, and would be expected to have an impact on well-being.
The study author (personal communication) notes that in Hong
Kong, where the study was carried out, this restraint would involve
residents wearing a ’safety jacket’, which would have an impact on
their mobility, comfort and possibly interaction, as well as increas-
ing irritability in some. In many countries, such restraint would
be seen as unethical; in others, there are concerns, but restraints
are still used (Kirkevold 2003). Reminiscence therapy has at its
core a respect for the person, as an individual, with a unique life
history (Woods 1998); restraint of any kind would be expected to
be seen as antithetical to good reminiscence practice.
4) With the exception of Lai 2004, the additional studies are
small and have some limitations. Thus, Morgan 2000 used a sin-
gle therapist who also conducted a proportion of the assessments.
Thorgrimsen 2002 had a very small control group at post-test (n
= 3), and relied heavily on family care-giver reports of the person’s
function; given the involvement of the care-giver in the groups,
this may have confounded the results obtained. For example, it is
possible that the improvements on the CAPE BRS could be in-
fluenced by the care-givers’ lowered stress levels, leading to more
positive ratings across the board. It is noticeable that the care-
givers’ ratings of QOL-AD in the reminiscence condition were
much more positive than those made by the people with dementia
themselves.
5) The largest trial (Lai 2004) seems to show fewer benefits for
the reminiscence condition. This is also the only study considered
here which included an active control group. This study largely
used different outcome measures from the other studies, with the
exception of the MMSE, where there was a significant effect at
follow-up, both in the comparison with no treatment and with the
social contact control. This study used WIB values to assess well-
being; this measure may reflect aspects of quality of care as much as
quality of life (Woods 2003), which means that aspects of the care
regime would have to change for this index to be affected greatly.
The routine use of physical restraint in this setting has already
been noted. Brooker 2000 found positive changes in WIB values
during reminiscence sessions, but the carry-over to the person’s
daily life would depend on staff input.
There were no indications from the outcome measures of the
four studies included in the current analysis of any harm or dis-
tress to people with dementia participating. The suggestion from
Goldwasser 1987 of increased depression associated with reminis-
cence is not supported by the included studies, where mood and
well-being showed no indications of negative change.
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A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence-base for the effectiveness of reminiscence therapy
continues to rest largely on descriptive and observational studies,
with the few RCTs available being small, of relatively low quality
and with some variation in outcome, perhaps related to the diverse
forms of RT used. It is too early to provide any indication of the
effectiveness of reminiscence therapy in comparison with other
psychosocial interventions, such as validation therapy or music
therapy. However, given its popularity with staff and participants,
there is no reason not to continue with its further development
and evaluation. The need for training, support and supervision
for staff carrying out this work is emphasised in much of the RT
literature.
Implications for research
There is a clear need for more randomized controlled trials of RT.
These need to follow a clear treatment protocol, so that it becomes
possible to define more precisely the key elements of the different
approaches to reminiscence work, and to evaluate their relative
benefits. The effects of severity of dementia and different modal-
ities (e.g. group versus individual versus with care-giver) need to
be systematically evaluated. The broadening of outcome measures
to include well-being, mood and quality of life is welcome, as is
a willingness to consider the impact on family and other care-
givers. Joint reminiscence work with people with dementia and
their family care-givers is a good example of relationship-centred
care, and may require the development of relationship-centred
outcome measures to evaluate fully its impact.
Any negative effects need to be reported on an individual basis,
so that it can begin to be possible to identify whether there are
some people with dementia on whom this approach has a harmful
impact.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Baines 1987
Methods Randomised controlled trial.
Cross-over design: 4 weeks treatment 1 + 4 weeks wash-out + 4 weeks treatment 2
Participants 15 subjects with moderate to severe impairment of cognitive functioning.
Mean age =81.5
Living in care home.
Interventions Reality Orientation
Reminiscence Therapy groups
No treatment
Outcomes Cognitive: Information/Orientation (CAPE)
Behavioural: Behaviour (CAPE)
Well-being: LSI
Communication: Holden
Notes Treatment is 30 minute sessions, 5 days per week for 4 weeks
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Goldwasser 1987
Methods Randomised controlled trial
Participants 27 subjects, clinical diagnosis of dementia.
Mean age = 82.3
Interventions Reminiscence therapy groups
Social support
No treatment
Outcomes Cognitive: Mini Mental State
Behavioural: Katz ADL
Well-being: Beck Depression Inventory
Notes 30 minute treatment sessions, twice weekly for five weeks.
Risk of bias
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Goldwasser 1987 (Continued)
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Lai 2004
Methods Randomised controlled trial
Participants 101 nursing home residents with DSM-IV diagnosis of dementia.
Mean age 85.7 years.
Interventions Reminiscence therapy (individualised)
Social support
No treatment
Outcomes Cognitive: MMSE
Behavioural: MDS-ADL
Communication: Social Engagement Scale (SES)
Well-being: DCM Well-being/ill-being scale (WIB)
Notes Treatment 30 minute sessions, weekly for 6 weeks. Assessors blind to group allocation
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Morgan 2000
Methods Randomised controlled trial
Participants 17 residential home residents with diagnosis of mild to moderate dementia
Interventions Individual life review
No treatment
Outcomes Well-being: Geriatric Depression Scale
Cognitive:
Autobiographical Memory Interview
Notes Treatment - average of 12 sessions. Assessors only partly blind to group allocation
Risk of bias
Item Authors’ judgement Description
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Morgan 2000 (Continued)
Allocation concealment? Unclear B - Unclear
Thorgrimsen 2002
Methods Randomised controlled trial
Participants 11 subjects with dementia.
Mean age 76.3
Living in community.
Interventions Reminiscence therapy (groups with carer involvement)
No treatment
Outcomes Cognitive: Mini Mental State
Behavioural: CAPE-BRS
Communication: Holden
Well-being: QOL-AD
Carer: GHQ-12, Relatives Stress Scale
Notes 18 weekly sessions - 11 for carers only.
Assessor blind to group allocation.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Baillon 2004 Reminiscence used as comparison treatment with Snoezelen. No other control group.
Three sessions of reminiscence only.
Brooker 2000 Within session, within-subjects design - no randomization.
Burckhardt 1987 Review article and meta-analysis of therapy for older people - not specific to reminiscence and dementia
Haight 2003 Randomization not mentioned
Head 1990 No randomization
McKee 2003 Reminiscence used with a general care home population. Data for people with dementia not presented separately
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(Continued)
McKiernan 1990 No randomization.
McMurdo 2000 Residential home population with MMSE>12; no diagnostic information provided; no data given for people
with dementia
Orrell 2000b Evaluation of cognitive stimulation - not reminiscence specifically
Orten 1989 Population without clear diagnosis of dementia.
Protomastro 1991 Intervention used a variety of methods - reminiscence only one aspect of this
Rattenbury 1989 Cognitive impairment was an exclusion factor for this study i.e. population did not have a clear diagnosis of
dementia
Thornton 1987 Review article.
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D A T A A N D A N A L Y S E S
Comparison 1. Reminiscence Therapy versus no treatment:
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Cognition post-treatment 4 103 Std. Mean Difference (IV, Fixed, 95% CI) 0.27 [-0.13, 0.67]
1.1 Information/Orientation
(CAPE)
1 10 Std. Mean Difference (IV, Fixed, 95% CI) -0.02 [-1.26, 1.22]
1.2 MMSE 2 76 Std. Mean Difference (IV, Fixed, 95% CI) 0.15 [-0.30, 0.61]
1.3 Autobiographical Memory
Interview
1 17 Std. Mean Difference (IV, Fixed, 95% CI) 1.04 [0.01, 2.08]
2 Behaviour post-treatment 3 Mean Difference (IV, Fixed, 95% CI) Subtotals only
2.1 CAPE (Behaviour) 2 20 Mean Difference (IV, Fixed, 95% CI) 7.61 [2.42, 12.80]
2.2 Problem Behaviour Rating
Scale
1 10 Mean Difference (IV, Fixed, 95% CI) 2.2 [-11.84, 16.24]
2.3 MDS-ADL 1 66 Mean Difference (IV, Fixed, 95% CI) 0.42 [-4.91, 5.75]
3 Communication and interaction
post-treatment
3 86 Std. Mean Difference (IV, Fixed, 95% CI) 0.01 [-0.42, 0.44]
3.1 Holden Communication
Scale
2 20 Std. Mean Difference (IV, Fixed, 95% CI) 0.23 [-0.68, 1.15]
3.2 Social Engagement Scale 1 66 Std. Mean Difference (IV, Fixed, 95% CI) -0.05 [-0.54, 0.43]
4 Well-being post-treatment 4 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 Life Satisfaction Index 2 27 Mean Difference (IV, Fixed, 95% CI) 0.75 [-2.53, 4.03]
4.2 QoL-AD (rated by person
with dementia)
1 10 Mean Difference (IV, Fixed, 95% CI) -5.5 [-15.52, 4.52]
4.3 QoL-AD (rated by carer) 1 10 Mean Difference (IV, Fixed, 95% CI) 5.3 [-0.15, 10.75]
4.4 WIB 1 66 Mean Difference (IV, Fixed, 95% CI) 0.04 [-0.14, 0.22]
4.5 Geriatric Depression Scale 1 17 Mean Difference (IV, Fixed, 95% CI) 1.28 [-0.98, 3.54]
5 Cognition at follow-up 3 93 Std. Mean Difference (IV, Fixed, 95% CI) 0.50 [0.07, 0.92]
5.1 Information / Orientation
(CAPE)
1 10 Std. Mean Difference (IV, Fixed, 95% CI) 0.42 [-0.84, 1.68]
5.2 Autobiographical Memory
Interview
1 17 Std. Mean Difference (IV, Fixed, 95% CI) 1.50 [0.39, 2.62]
5.3 MMSE 1 66 Std. Mean Difference (IV, Fixed, 95% CI) 0.31 [-0.17, 0.80]
6 Behaviour at follow-up 2 Mean Difference (IV, Fixed, 95% CI) Subtotals only
6.1 CAPE (Behaviour) 1 10 Mean Difference (IV, Fixed, 95% CI) -0.20 [-8.56, 8.16]
6.2 Problem Behaviour Rating
Scale
1 10 Mean Difference (IV, Fixed, 95% CI) 1.6 [-10.79, 13.99]
6.3 MDS-ADL 1 66 Mean Difference (IV, Fixed, 95% CI) 0.45 [-4.87, 5.77]
7 Communication and interaction
at follow-up
2 76 Std. Mean Difference (IV, Fixed, 95% CI) 0.16 [-0.29, 0.61]
7.1 Holden Communication
Scale
1 10 Std. Mean Difference (IV, Fixed, 95% CI) -0.11 [-1.35, 1.13]
7.2 Social Engagement Scale 1 66 Std. Mean Difference (IV, Fixed, 95% CI) 0.20 [-0.29, 0.69]
8 Well-being at follow-up 3 Mean Difference (IV, Fixed, 95% CI) Subtotals only
8.1 Life Satisfaction Index 2 27 Mean Difference (IV, Fixed, 95% CI) 2.87 [-1.28, 7.01]
8.2 WIB 1 66 Mean Difference (IV, Fixed, 95% CI) 0.06 [-0.13, 0.25]
8.3 Geriatric Depression Scale 1 17 Mean Difference (IV, Fixed, 95% CI) 3.69 [1.65, 5.73]
16Reminiscence therapy for dementia (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
9 Carer strain at post-treatment 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 General Health
Questionnaire (12)
1 10 Mean Difference (IV, Fixed, 95% CI) 2.9 [0.22, 5.58]
9.2 Relatives Stress Scale 1 10 Mean Difference (IV, Fixed, 95% CI) 18.8 [6.45, 31.15]
10 Staff knowledge of person with
dementia
1 10 Mean Difference (IV, Fixed, 95% CI) 19.8 [15.64, 23.96]
Comparison 2. Reminiscence Therapy versus social contact
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Communication and interaction
at post-treatment
1 71 Mean Difference (IV, Fixed, 95% CI) -0.27 [-1.41, 0.87]
1.1 Social Engagement Scale 1 71 Mean Difference (IV, Fixed, 95% CI) -0.27 [-1.41, 0.87]
2 Well-being at post-treatment 1 71 Mean Difference (IV, Fixed, 95% CI) 0.02 [-0.13, 0.17]
2.1 WIB 1 71 Mean Difference (IV, Fixed, 95% CI) 0.02 [-0.13, 0.17]
3 Communication and interaction
at follow-up
1 71 Mean Difference (IV, Fixed, 95% CI) -0.33 [-1.37, 0.71]
3.1 Social Engagement Scale 1 71 Mean Difference (IV, Fixed, 95% CI) -0.33 [-1.37, 0.71]
4 Well-being at follow-up 1 71 Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.12, 0.18]
4.1 WIB 1 71 Mean Difference (IV, Fixed, 95% CI) 0.03 [-0.12, 0.18]
5 Cognition at post-treatment 1 71 Mean Difference (IV, Fixed, 95% CI) 1.45 [-1.77, 4.67]
5.1 MMSE 1 71 Mean Difference (IV, Fixed, 95% CI) 1.45 [-1.77, 4.67]
6 Behaviour at post-treatment 1 71 Mean Difference (IV, Fixed, 95% CI) -1.5 [-6.96, 3.96]
6.1 MDS-ADL 1 71 Mean Difference (IV, Fixed, 95% CI) -1.5 [-6.96, 3.96]
7 Cognition at follow-up 1 71 Mean Difference (IV, Fixed, 95% CI) 4.37 [0.72, 8.02]
7.1 MMSE 1 71 Mean Difference (IV, Fixed, 95% CI) 4.37 [0.72, 8.02]
8 Behaviour at follow-up 1 71 Mean Difference (IV, Fixed, 95% CI) 0.82 [-4.43, 6.07]
8.1 MDS-ADL 1 71 Mean Difference (IV, Fixed, 95% CI) 0.82 [-4.43, 6.07]
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Analysis 1.1. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 1 Cognition post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 1 Cognition post-treatment
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Information/Orientation (CAPE)
Baines 1987 5 0 (4.27) 5 0.1 (6.4) 10.2 % -0.02 [ -1.26, 1.22 ]
Subtotal (95% CI) 5 5 10.2 % -0.02 [ -1.26, 1.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
2 MMSE
Lai 2004 36 0.6 (6.91) 30 -0.14 (8.96) 67.0 % 0.09 [ -0.39, 0.58 ]
Thorgrimsen 2002 7 0.2 (6) 3 -3.7 (0.6) 8.0 % 0.68 [ -0.73, 2.08 ]
Subtotal (95% CI) 43 33 75.0 % 0.15 [ -0.30, 0.61 ]
Heterogeneity: Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
3 Autobiographical Memory Interview
Morgan 2000 8 11.69 (14.82) 9 -1.39 (8.52) 14.8 % 1.04 [ 0.01, 2.08 ]
Subtotal (95% CI) 8 9 14.8 % 1.04 [ 0.01, 2.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.98 (P = 0.047)
Total (95% CI) 56 47 100.0 % 0.27 [ -0.13, 0.67 ]
Heterogeneity: Chi2 = 3.20, df = 3 (P = 0.36); I2 =6%
Test for overall effect: Z = 1.33 (P = 0.18)
Test for subgroup differences: Chi2 = 2.61, df = 2 (P = 0.27), I2 =23%
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Analysis 1.2. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 2 Behaviour post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 2 Behaviour post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 CAPE (Behaviour)
Baines 1987 5 -2.5 (10.22) 5 -1.2 (9.37) 18.2 % -1.30 [ -13.45, 10.85 ]
Thorgrimsen 2002 7 6.3 (7.4) 3 -3.3 (1.5) 81.8 % 9.60 [ 3.86, 15.34 ]
Subtotal (95% CI) 12 8 100.0 % 7.61 [ 2.42, 12.80 ]
Heterogeneity: Chi2 = 2.53, df = 1 (P = 0.11); I2 =60%
Test for overall effect: Z = 2.88 (P = 0.0040)
2 Problem Behaviour Rating Scale
Baines 1987 5 0.4 (9.61) 5 -1.8 (12.82) 100.0 % 2.20 [ -11.84, 16.24 ]
Subtotal (95% CI) 5 5 100.0 % 2.20 [ -11.84, 16.24 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
3 MDS-ADL
Lai 2004 36 -0.43 (11.38) 30 -0.85 (10.69) 100.0 % 0.42 [ -4.91, 5.75 ]
Subtotal (95% CI) 36 30 100.0 % 0.42 [ -4.91, 5.75 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
Test for subgroup differences: Chi2 = 3.66, df = 2 (P = 0.16), I2 =45%
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Analysis 1.3. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 3 Communication and
interaction post-treatment.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 3 Communication and interaction post-treatment
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Holden Communication Scale
Baines 1987 5 0.7 (6.22) 5 -2.6 (12.5) 11.7 % 0.30 [ -0.95, 1.55 ]
Thorgrimsen 2002 7 4.2 (7.9) 3 3 (2.7) 10.0 % 0.16 [ -1.20, 1.51 ]
Subtotal (95% CI) 12 8 21.7 % 0.23 [ -0.68, 1.15 ]
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.50 (P = 0.62)
2 Social Engagement Scale
Lai 2004 36 0.42 (2.43) 30 0.55 (2.26) 78.3 % -0.05 [ -0.54, 0.43 ]
Subtotal (95% CI) 36 30 78.3 % -0.05 [ -0.54, 0.43 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.83)
Total (95% CI) 48 38 100.0 % 0.01 [ -0.42, 0.44 ]
Heterogeneity: Chi2 = 0.32, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Chi2 = 0.30, df = 1 (P = 0.59), I2 =0.0%
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Analysis 1.4. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 4 Well-being post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 4 Well-being post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Life Satisfaction Index
Baines 1987 5 0.6 (8.78) 5 0.2 (4.65) 14.2 % 0.40 [ -8.31, 9.11 ]
Morgan 2000 8 1.25 (3.69) 9 0.44 (3.75) 85.8 % 0.81 [ -2.73, 4.35 ]
Subtotal (95% CI) 13 14 100.0 % 0.75 [ -2.53, 4.03 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.45 (P = 0.65)
2 QoL-AD (rated by person with dementia)
Thorgrimsen 2002 7 -0.2 (3.2) 3 5.3 (8.6) 100.0 % -5.50 [ -15.52, 4.52 ]
Subtotal (95% CI) 7 3 100.0 % -5.50 [ -15.52, 4.52 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
3 QoL-AD (rated by carer)
Thorgrimsen 2002 7 0.3 (6.1) 3 -5 (2.7) 100.0 % 5.30 [ -0.15, 10.75 ]
Subtotal (95% CI) 7 3 100.0 % 5.30 [ -0.15, 10.75 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.90 (P = 0.057)
4 WIB
Lai 2004 36 0.11 (0.31) 30 0.07 (0.43) 100.0 % 0.04 [ -0.14, 0.22 ]
Subtotal (95% CI) 36 30 100.0 % 0.04 [ -0.14, 0.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
5 Geriatric Depression Scale
Morgan 2000 8 1.5 (3.02) 9 0.22 (1.3) 100.0 % 1.28 [ -0.98, 3.54 ]
Subtotal (95% CI) 8 9 100.0 % 1.28 [ -0.98, 3.54 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Chi2 = 6.06, df = 4 (P = 0.19), I2 =34%
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Analysis 1.5. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 5 Cognition at follow-up.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 5 Cognition at follow-up
Study or subgroup Reminiscence No treatment
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Information / Orientation (CAPE)
Baines 1987 5 0.2 (4.7) 5 -2.3 (5.94) 11.1 % 0.42 [ -0.84, 1.68 ]
Subtotal (95% CI) 5 5 11.1 % 0.42 [ -0.84, 1.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.65 (P = 0.51)
2 Autobiographical Memory Interview
Morgan 2000 8 9.5 (14.02) 9 -5.95 (2.48) 14.3 % 1.50 [ 0.39, 2.62 ]
Subtotal (95% CI) 8 9 14.3 % 1.50 [ 0.39, 2.62 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.65 (P = 0.0081)
3 MMSE
Lai 2004 36 3.38 (8.63) 30 0.6 (8.95) 74.6 % 0.31 [ -0.17, 0.80 ]
Subtotal (95% CI) 36 30 74.6 % 0.31 [ -0.17, 0.80 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
Total (95% CI) 49 44 100.0 % 0.50 [ 0.07, 0.92 ]
Heterogeneity: Chi2 = 3.71, df = 2 (P = 0.16); I2 =46%
Test for overall effect: Z = 2.31 (P = 0.021)
Test for subgroup differences: Chi2 = 3.71, df = 2 (P = 0.16), I2 =46%
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Analysis 1.6. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 6 Behaviour at follow-up.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 6 Behaviour at follow-up
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 CAPE (Behaviour)
Baines 1987 5 -0.2 (7.78) 5 0 (5.51) 100.0 % -0.20 [ -8.56, 8.16 ]
Subtotal (95% CI) 5 5 100.0 % -0.20 [ -8.56, 8.16 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
2 Problem Behaviour Rating Scale
Baines 1987 5 1.8 (8.72) 5 0.2 (11.12) 100.0 % 1.60 [ -10.79, 13.99 ]
Subtotal (95% CI) 5 5 100.0 % 1.60 [ -10.79, 13.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
3 MDS-ADL
Lai 2004 36 0.6 (10.8) 30 0.15 (11.11) 100.0 % 0.45 [ -4.87, 5.77 ]
Subtotal (95% CI) 36 30 100.0 % 0.45 [ -4.87, 5.77 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
Test for subgroup differences: Chi2 = 0.06, df = 2 (P = 0.97), I2 =0.0%
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Analysis 1.7. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 7 Communication and
interaction at follow-up.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 7 Communication and interaction at follow-up
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Holden Communication Scale
Baines 1987 5 0 (6.22) 5 1.2 (12.81) 13.3 % -0.11 [ -1.35, 1.13 ]
Subtotal (95% CI) 5 5 13.3 % -0.11 [ -1.35, 1.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
2 Social Engagement Scale
Lai 2004 36 0.64 (2.04) 30 0.21 (2.22) 86.7 % 0.20 [ -0.29, 0.69 ]
Subtotal (95% CI) 36 30 86.7 % 0.20 [ -0.29, 0.69 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
Total (95% CI) 41 35 100.0 % 0.16 [ -0.29, 0.61 ]
Heterogeneity: Chi2 = 0.20, df = 1 (P = 0.65); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.65), I2 =0.0%
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Analysis 1.8. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 8 Well-being at follow-
up.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 8 Well-being at follow-up
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Life Satisfaction Index
Baines 1987 5 1.6 (8.61) 5 -1.4 (7.44) 17.3 % 3.00 [ -6.97, 12.97 ]
Morgan 2000 8 3.5 (4.63) 9 0.66 (4.95) 82.7 % 2.84 [ -1.72, 7.40 ]
Subtotal (95% CI) 13 14 100.0 % 2.87 [ -1.28, 7.01 ]
Heterogeneity: Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 1.36 (P = 0.17)
2 WIB
Lai 2004 36 0.11 (0.3) 30 0.05 (0.47) 100.0 % 0.06 [ -0.13, 0.25 ]
Subtotal (95% CI) 36 30 100.0 % 0.06 [ -0.13, 0.25 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
3 Geriatric Depression Scale
Morgan 2000 8 3.25 (2.05) 9 -0.44 (2.24) 100.0 % 3.69 [ 1.65, 5.73 ]
Subtotal (95% CI) 8 9 100.0 % 3.69 [ 1.65, 5.73 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.55 (P = 0.00039)
Test for subgroup differences: Chi2 = 13.78, df = 2 (P = 0.00), I2 =85%
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Analysis 1.9. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 9 Carer strain at post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 9 Carer strain at post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 General Health Questionnaire (12)
Thorgrimsen 2002 7 1.2 (2.8) 3 -1.7 (1.5) 100.0 % 2.90 [ 0.22, 5.58 ]
Subtotal (95% CI) 7 3 100.0 % 2.90 [ 0.22, 5.58 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.12 (P = 0.034)
2 Relatives Stress Scale
Thorgrimsen 2002 7 11.5 (13.5) 3 -7.3 (6.4) 100.0 % 18.80 [ 6.45, 31.15 ]
Subtotal (95% CI) 7 3 100.0 % 18.80 [ 6.45, 31.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.98 (P = 0.0028)
Test for subgroup differences: Chi2 = 6.08, df = 1 (P = 0.01), I2 =84%
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Analysis 1.10. Comparison 1 Reminiscence Therapy versus no treatment:, Outcome 10 Staff knowledge of
person with dementia.
Review: Reminiscence therapy for dementia
Comparison: 1 Reminiscence Therapy versus no treatment:
Outcome: 10 Staff knowledge of person with dementia
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Baines 1987 5 19.8 (3.81) 5 0 (2.83) 100.0 % 19.80 [ 15.64, 23.96 ]
Total (95% CI) 5 5 100.0 % 19.80 [ 15.64, 23.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 9.33 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Reminiscence Therapy versus social contact, Outcome 1 Communication and
interaction at post-treatment.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 1 Communication and interaction at post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Social Engagement Scale
Lai 2004 36 0.42 (2.43) 35 0.69 (2.49) 100.0 % -0.27 [ -1.41, 0.87 ]
Total (95% CI) 36 35 100.0 % -0.27 [ -1.41, 0.87 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Reminiscence Therapy versus social contact, Outcome 2 Well-being at post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 2 Well-being at post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 WIB
Lai 2004 36 0.11 (0.31) 35 0.09 (0.35) 100.0 % 0.02 [ -0.13, 0.17 ]
Total (95% CI) 36 35 100.0 % 0.02 [ -0.13, 0.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Reminiscence Therapy versus social contact, Outcome 3 Communication and
interaction at follow-up.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 3 Communication and interaction at follow-up
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Social Engagement Scale
Lai 2004 36 0.64 (2.01) 35 0.97 (2.45) 100.0 % -0.33 [ -1.37, 0.71 ]
Total (95% CI) 36 35 100.0 % -0.33 [ -1.37, 0.71 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.54)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Reminiscence Therapy versus social contact, Outcome 4 Well-being at follow-
up.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 4 Well-being at follow-up
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 WIB
Lai 2004 36 0.11 (0.3) 35 0.08 (0.34) 100.0 % 0.03 [ -0.12, 0.18 ]
Total (95% CI) 36 35 100.0 % 0.03 [ -0.12, 0.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Reminiscence Therapy versus social contact, Outcome 5 Cognition at post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 5 Cognition at post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 MMSE
Lai 2004 36 0.6 (6.91) 35 -0.85 (6.93) 100.0 % 1.45 [ -1.77, 4.67 ]
Total (95% CI) 36 35 100.0 % 1.45 [ -1.77, 4.67 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.88 (P = 0.38)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Reminiscence Therapy versus social contact, Outcome 6 Behaviour at post-
treatment.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 6 Behaviour at post-treatment
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 MDS-ADL
Lai 2004 36 -0.43 (12.3) 35 1.07 (11.18) 100.0 % -1.50 [ -6.96, 3.96 ]
Total (95% CI) 36 35 100.0 % -1.50 [ -6.96, 3.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Reminiscence Therapy versus social contact, Outcome 7 Cognition at follow-up.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 7 Cognition at follow-up
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 MMSE
Lai 2004 36 3.38 (8.63) 35 -0.99 (6.99) 100.0 % 4.37 [ 0.72, 8.02 ]
Total (95% CI) 36 35 100.0 % 4.37 [ 0.72, 8.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.35 (P = 0.019)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Reminiscence Therapy versus social contact, Outcome 8 Behaviour at follow-up.
Review: Reminiscence therapy for dementia
Comparison: 2 Reminiscence Therapy versus social contact
Outcome: 8 Behaviour at follow-up
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 MDS-ADL
Lai 2004 36 0.6 (10.8) 35 -0.22 (11.74) 100.0 % 0.82 [ -4.43, 6.07 ]
Total (95% CI) 36 35 100.0 % 0.82 [ -4.43, 6.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Outcome measures
Name of measure Source Description Maximum score How completed?
MMSE Folstein 1975 Widely used test of cog-
nitive function - includes
orientation and learn-
ing items, language and
praxis
30 Questions asked in interview
with person with dementia
Information / Orienta-
tion (CAPE)
Pattie 1979 Brief measure of ver-
bal orientation. Part of
Clifton Assessment Pro-
cedures for the Elderly
(CAPE)
10 Questions asked in interview
with person with dementia
Autobiographical Mem-
ory Interview - Personal
Semantic Schedule
Kopelman 1990 Assesses recall of per-
sonal facts from three
time periods: childhood,
early adulthood and later
adulthood
63 Questions asked in interview
with person with dementia
32Reminiscence therapy for dementia (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Outcome measures (Continued)
Holden
Communication Scale
Holden 1995 Assesses conversation,
communication and so-
cial awareness. 12 items
rated 0-4
48 Completed by member of staff
or relative from their observa-
tion of the person with demen-
tia over a specified period
Social Engagement Scale Schroll 1997 Assesses ease of inter-
action and social en-
gagement over previous
week. 6 items rated 0 or
1
6 Completed by member of staff
or relative from their observa-
tion of the person with demen-
tia over a specified period
Behaviour Rating Scale
(CAPE)
Pattie 1979 Assesses level of depen-
dency and behaviour.
Part of CAPE.
36 Completed by member of staff
or relative from their observa-
tion of the person with demen-
tia over a specified period
MDS-ADL Morris 1997 Assesses activities of daily
living and degree of de-
pendency. Part of Mini-
mum Data Set - Home
Care (MDS-HC)
46 Completed by member of staff
or relative from their observa-
tion of the person with demen-
tia over a specified period
Problem Behaviour Rat-
ing Scale
Jeffery 1981 Assesses ’specific
behaviour patterns asso-
ciated with confusion’.
Each area assessed with a
7 point scale, but no de-
tails of number of areas
Not stated Completed by member of staff
or relative from their observa-
tion of the person with demen-
tia over a specified period
Life Satisfaction Index Adams 1969 Assesses person’s sense of
achievement and con-
tentment with life
18 Questions asked in interview
with person with dementia
QOL-AD Logsdon 1999 13 items, rated 1-4, cov-
ering different domains
of the quality of life of
the person with demen-
tia. Proxy rating possi-
ble (e.g. by relative), but
not identical with per-
son’s own rating
52 Completed either in interview
with person with dementia or
by family care-giver from their
observation of the person with
dementia
WIB (Dementia Care
Mapping)
Bradford Dementia
Group 1997
Dementia Care Map-
ping involves direct ob-
servation of the person
with dementia for a min-
imum of 6 hours. Ev-
ery five minutes, the per-
son’s Well-being / Ill-be-
5 Average of ratings every 5 min-
utes for at least 6 hours
33Reminiscence therapy for dementia (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Outcome measures (Continued)
ing is recorded on a 6
point scale (-5 to +5).
The WIB score is the
mean of these observa-
tions
Geriatric Depression
Scale
Yesavage 1983 Widely used self-report
depression scale - each
item has a ’Yes/No’ re-
sponse format. Scores of
5 and above are con-
sidered in the depressed
range
15 Questions asked in interview
with person with dementia
GHQ-12 Goldberg 1978 A brief version of the
General Health
Questionnaire, which as-
sesses psychological dis-
tress and has been used
in many care-giver stud-
ies
12 Care-giver completes self-re-
port questionnaire.
Relatives Stress Scale Greene 1982 Widely used 12 item
scale assessing distress
arising specifically from
care-giving
48 Care-giver completes self-re-
port questionnaire
Staff Knowledge Baines 1987 Assessed using the Per-
sonal Informa-
tion Questionnaire, ask-
ing basic questions about
the person’s family, for-
mer work roles and past
and present hobbies and
interests
40 Staff complete questionnaire
about each resident without re-
ferring to records
WH A T ’ S N E W
Last assessed as up-to-date: 5 February 2005.
Date Event Description
6 November 2008 Amended Converted to new review format.
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H I S T O R Y
Protocol first published: Issue 2, 1998
Review first published: Issue 3, 1998
Date Event Description
6 February 2005 New citation required and conclusions have changed The review has been substantially updated and rewritten
following the publication of three new trials
C O N T R I B U T I O N S O F A U T H O R S
Original version and first update:
-AS: all correspondence; drafting of review versions; updating of review; selection of trials; extraction of data; interpretation of data
analyses
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analyses
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